Objective: To compare incremental costs associated with complications of elective colectomy using nationally representative data among patients undergoing laparoscopic/open resections for the 4 most frequent diagnoses.
Summary Background Data: Rising healthcare costs have led to increasing focus on the need to achieve a better understanding of the association between costs and quality. Among elective colectomies, a focus of surgical quality-improvement initiatives, interpretable evidence to support existing approaches is lacking.
Methods: The 2009 to 2011 Nationwide Inpatient Sample (NIS) data were queried for adult (≥18 years) patients undergoing elective colectomy. Patients with primary diagnoses for colon cancer, diverticular disease, benign colonic neoplasm, and ulcerative colitis/regional enteritis were included. Based on system-based complications considered relevant to long-term treatment of elective colectomy, stratified differences in risk-adjusted incremental hospital costs and complications probabilities were compared.
Results: A total of 68,462 patients were included, weighted to represent 337,887 patients nationwide. A total of 16.4% experienced complications. Annual risk-adjusted incremental costs amounted to >$150 million. Magnitudes of complication prevalences/costs varied by primary diagnosis, operative technique, and complication group. Infectious complications contributed the most ($55 million), followed by gastrointestinal ($53 million), pulmonary ($22 million), and cardiovascular ($11 million) complications. Total annual costs for elective colectomies amounted to >$1.7 billion: 11.3% was due to complications [1.9% due to current Centers for Medicare and Medicaid Services (CMS) complications].
Conclusions: The results highlight a need to consider the varied/broad impact of complications, offering a stratified paradigm for priority setting in surgery. As we move forward in the development of novel/adaptation of existing interventions, it will be essential to weigh the cost of complications in an evidence-based way.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1097/SLA.0000000000001511 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Effect of obesity on postoperative complications in ulcerative colitis: A systematic review and meta-analysis.
Ann Gastroenterol Surg
January 2025
Department of Surgery, Transplantation and Gastroenterology Semmelweis University Budapest Hungary.
Article Synopsis
- The study investigates the impact of obesity on postoperative complications in ulcerative colitis patients undergoing a specific surgery (IPAA).
- Results showed no significant difference in overall complication rates between obese and non-obese patients, though obese patients had slightly longer hospital stays.
- The findings highlight low certainty of evidence, suggesting further research is needed to draw definitive conclusions.
The Long-Term Prognostic Outcomes of Emergent Colon Cancer Surgery: A Single-Center Experience.
Ann Ital Chir
December 2024
Department of General Surgery, Marmara University Pendik Training and Research Hospital, 34899 Istanbul, Türkiye.
Aim: Colorectal cancer (CRC) ranks as the second most diagnosed and third most deadly cancer worldwide. Despite advances in early diagnosis and treatment, CRC remains a leading cause of cancer-related deaths. Up to 30% of CRC patients are diagnosed during emergency department visits, leading to surgical procedures that may not adhere to oncological principles due to complications like obstruction, bleeding, or perforation.
View Article and Find Full Text PDFC-reactive Protein as a Negative Predictor of Anastomotic Leak Following Elective Colorectal Resection: A Beacon of Assurance?
Cureus
November 2024
Department of Colorectal Surgery, The Royal Wolverhampton NHS Trust, Wolverhampton, GBR.
Background To evaluate the accuracy and optimal C-reactive protein (CRP) level for detecting anastomotic leak (AL) in patients following elective colorectal resection. Methods A retrospective data collection of patients undergoing elective colorectal resection with primary anastomosis at a single institution was performed. Data were collected between June 2021 and November 2022.
View Article and Find Full Text PDFDevelopment and internal validation of time-to-event risk prediction models for major medical complications within 30 days after elective colectomy.
PLoS One
December 2024
Department of Anesthesiology, Pharmacology & Therapeutics, Faculty of Medicine, The University of British Columbia, Vancouver, British Columbia, Canada.
Background: Patients undergoing colectomy are at risk of numerous major complications. However, existing binary risk stratification models do not predict when a patient may be at highest risks of each complication. Accurate prediction of the timing of complications facilitates targeted, resource-efficient monitoring.
View Article and Find Full Text PDFIntravenous Lidocaine for Gut Function Recovery in Colonic Surgery: A Randomized Clinical Trial.
JAMA
January 2025
Edinburgh Clinical Trials Unit, University of Edinburgh, Edinburgh, United Kingdom.
Importance: Despite the recovery advantages of minimally invasive surgical techniques, delayed return of gut function after colectomy is a common barrier to timely discharge from hospital.
Objective: To evaluate the effect of 2% perioperative intravenous lidocaine infusion on return of gut function after elective minimally invasive colon resection.
Design, Setting, And Participants: The ALLEGRO trial was a randomized, placebo-controlled, double-blind trial conducted in 27 UK hospitals.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!